ESPE Abstracts (2014) 82 P-D-2-1-285

Mutations in IFITM5 Leading to Prenatal and Postnatal Signs of Dominant Osteogenesis Imperfecta

Heike Hoyer-Kuhna, Christian Netzerb, Jutta Beckerb, Eckhard Schoenaua & Oliver Semlera


aChildren’s Hospital, University of Cologne, Cologne, Germany; bInstitute of Human Genetics, University of Cologne, Cologne, Germany


Introduction: Osteogenesis imperfecta (OI) is a hereditary disease characterized by a wide range of skeletal signs. Mutations in COL1A1/A2 have been known to cause dominant OI. Recently, a heterozygous mutation in the 5′-UTR of IFITM5 (c.−14C>T) was identified as a new cause of dominant OI. We present three patients from three different families with two mutations in IFITM5 with extremely different phenotypes.

Description of methods/design: Patient 1 displayed at 20 weeks of gestation with bowing of the lower extremities. Postnatal, he showed white sclera, a hypoplastic thorax, bowing of the long bones. With 19 months the patient presented with a length of −4.8 SDS and a weight of −3.2 SDS. Bone resorption was increased despite antiresorptive bisphosphonate treatment (deoxypyridinoline/creatinine 63.9 nM/mM (19.5±7.2). Patient 2 and 3 were diagnosed with a moderate OI at the age of 1.7/8.7 years based on extremity fractures and hyperplastic callus formation. Bone mineral density was reduced with a DXA ap spine Z-score of −3.3/−2.8 before initiating i.v./oral bisphosphonate treatment. Sanger sequencing of IFITM5 was performed. Written informed consent was given.

Results: In patients 2/3 the IFITM5 c.−14C>T mutation was identified causing the classical postnatal hallmarks of OI V. Patient 1 presented a new heterozygous mutation within the coding region of IFITM5 (c.119C>T; p.S40L). This mutation resulted in severe OI with prenatal onset and extreme short stature. Characteristics of OI type V did not occur yet.

Conclusions: Dominant mutations in the gene IFITM5 are connected to the clinical hallmarks of moderate OI V but also can lead to severe OI with prenatal onset. In patients suspected of OI, the entire gene IFITM5 – and not only the 5′-UTR region– has to be analyzed to exclude a causal role of IFITM5. We propose that this should be part of the initial diagnostic steps as dominant mutations are most common in OI.

Article tools

My recent searches

No recent searches.